Influenza Virus Type A and B SARS-CoV-2, PCR
Influenza is a highly contagious, acute, viral infection of the respiratory tract caused by Influenza virus type A and type B. The disease is easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months. Influenza type A and B viruses are a RNA virus belonging to the family of orthomyxoviridae. Type A influenza viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B influenza infections are usually milder. Rapid diagnosis of influenza A and B has become more important due to the availability of effective antiviral therapy. Rapid diagnosis of influenza can lead to reduced hospital stays, antimicrobial use and cost of care.
However, Influenza testing is mostly used in cases where patients have weakened immune systems and at the start of flu season. Although, culture is still the gold standard method for detection and diagnosis of influenza virus, currently rapid tests by molecular method are more and more used for detection of infection. These tests have ability to report results in hours or days giving a physician ability for early detection and treatment. The ELISA and rapid immunoassay are still available and use, but their specificity and sensitivity lag in comparison to molecular tests.
SARS-CoV-2 is a positive-sense, single-stranded RNA coronavirus (+ssRNA) belongs to the 2B group of the betacoronavirus family, which is the same family as SARS-CoV and MERS-CoV and has 70% similarity in genetic sequence to SARS. SARS-CoV-2 is the causative agent of coronavirus disease 2019 (COVID-19). Symptoms of COVID-19 range from mild fever, cough, and shortness of breath, muscle pain, diarrhea, and sore throat to pneumonia and multi-organ failure. The disease is transmitted from human-to-human by close contact, via respiratory droplets generated by sneezing and coughing. It may also spread when one touches a contaminated surface and then their face. The incubation period appears to be 2-14 days. Detection of the viral RNA by molecular method such as reverse transcriptase polymerase chain reaction (RT-PCR) is preferable and widely adopted test in COVID-19 testing, especially for early detection and infection spreading management.
- Early detection of influenza virus infection
- Early detection of COVID-19 viral infection
- Disease treatment and management
Positive results will indicate infection with influenza virus or/and SARS-CoV-2.
Patient infection could be treated with antiviral therapy, especially young children; elderly and immunocompromised patients.
Not Detected (Negative)
Multiplex Real‐time reverse transcription‐polymerase chain reaction (PCR), transcription mediated amplification (TMA), other molecular methods.
Nasopharyngeal swab, nasal swab, oropharyngeal swab collected in a viral transport media. Nasopharyngeal washing, Bronchial washing or bronchoalveolar lavage fluid in a sterile container.
Stability
- Ambient: 1-3 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Curr Opin Pediatr. 2011 Feb;23(1):91-7. [PMID: 21150446]
- J Clin Virol. 2017 Aug 8;95:5-9. [PMID: 28818691]
- Future Microbiol. 2013 Apr;8(4):435-44. [PMID: 23534357]
- J Clin Virol. 2017 Jul 26;94:86-90. [PMID: 28772170]
- Alan H.B Wu. Tietz clinical guide to laboratory tests. 2006, Fourth edition. WB Saunders Company.
- David S Jacobs et al. Laboratory test Handbook. 2001, 5th edition. Lexi-Comp Inc
- Rapid Influenza Diagnostic Test. Atlanta, Georgia: Center for Disease Control;[ 8/8/2017],https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
- WHO information for molecular diagnosis of influenza virus – update, 3/2014: Geneva Swittzerland; World Health Organization